By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genia, a Mountain View, Calif.-based startup, is developing a semiconductor-based nanopore sequencing platform that it believes will show promise for molecular diagnostic applications.

Stefan Roever, CEO and founder of the company, told GenomeWeb Daily News this week that the company has an alpha version of its single-molecule platform in hand and is currently optimizing the biochemistry for a beta system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.